T cell recognition of autoantigens in human type 1 diabetes: Clinical perspectives

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Mallone, Roberto ^a,b,c   Brezar, Vedran ^a,b   Boitard, Christian ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AUTOANTIGEN; C PEPTIDE; CD38 ANTIGEN; CHROMOGRANIN; EPITOPE; FREUND ADJUVANT; GAMMA INTERFERON; GLIMA 38; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 70; HLA DQ8 ANTIGEN; HLA DR4 ANTIGEN; IGRP; INSULIN; INSULIN ZINC SUSPENSION; INTERLEUKIN 10; ISLET ANTIGEN 2; ISLET ANTIGEN 2 BETA; ISOPHANE INSULIN; PANCREAS ISLET CELL ANTIBODY; PHOGRIN; PROINSULIN; UNCLASSIFIED DRUG; ZNT8; AUTOANTIBODY; HLA D ANTIGEN; PREPROINSULIN; PROTEIN PRECURSOR;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELLULAR DISTRIBUTION; CLINICAL EVALUATION; CONTINUOUS INFUSION; CYTOKINE PRODUCTION; FOLLOW UP; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; LOW DRUG DOSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NEUROENDOCRINE DISEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; REVIEW; RISK ASSESSMENT; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; AMINO ACID SEQUENCE; ANIMAL; AUTOIMMUNITY; BLOOD; CLINICAL TRIAL (TOPIC); EXPERIMENTAL DIABETES MELLITUS; HELPER CELL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; C-PEPTIDE; CD8-POSITIVE T-LYMPHOCYTES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; EPITOPES, T-LYMPHOCYTE; GLUTAMATE DECARBOXYLASE; HLA-D ANTIGENS; HUMANS; IMMUNE TOLERANCE; INSULIN; INSULIN-SECRETING CELLS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PROTEIN PRECURSORS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 80052695684     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/513210     Document Type: Review

References (142)

1. Faideau B., Larger E., Lepault F., Carel J. C., Boitard C., Role of -cells in type 1 diabetes pathogenesis Diabetes 2005 54 2 S87 S96
2. Anderson M. S., Bluestone J. A., The NOD mouse: a model of immune dysregulation Annual Review of Immunology 2005 23 447 485 (Pubitemid 40563177)
3. Rogner U. C., Boitard C., Morin J., Melanitou E., Avner P., Three loci on mouse chromosome 6 influence onset and final incidence of type I diabetes in NOD.C3H congenic strains Genomics 2001 74 2 163 171 (Pubitemid 32550137)
4. Todd J. A., Etiology of type 1 diabetes Immunity 2010 32 4 457 467
5. Itoh N., Hanafusa T., Miyazaki A., Miyagawa J. I., Yamagata K., Yamamoto K., Waguri M., Imagawa A., Tamura S., Inada M., Kawata S., Tarui S., Kono N., Matsuzawa Y., Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients The Journal of Clinical Investigation 1993 92 5 2313 2322 (Pubitemid 23333537)
6. Somoza N., Vargas F., Roura-Mir C., Vives-Pi M., Fernandez-Figueras M. T., Ariza A., Gomis R., Bragado R., Marti M., Jaraquemada D., Pujol-Borrell R., Pancreas in recent onset insulin-dependent diabetes mellitus: changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V usage, and cytokine profile The Journal of Immunology 1994 153 3 1360 1377 (Pubitemid 24228529)
7. Willcox A., Richardson S. J., Bone A. J., Foulis A. K., Morgan N. G., Analysis of islet inflammation in human type 1 diabetes Clinical and Experimental Immunology 2009 155 2 173 181
8. Hanninen A., Jalkanen S., Salmi M., Toikkanen S., Nikolakaros G., Simell O., Macrophages, T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus The Journal of Clinical Investigation 1992 90 5 1901 1910
9. Bottazzo G. F., Dean B. M., McNally J. M., In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis The New England Journal of Medicine 1985 313 6 353 360 (Pubitemid 15046367)
10. Foulis A. K., McGill M., Farquharson M. A., Insulitis in type 1 (insulin-dependent) diabetes mellitus in manmacrophages, lymphocytes, and interferon- containing cells Journal of Pathology 1991 165 2 97 103
11. Willcox A., Richardson S. J., Bone A. J., Foulis A. K., Morgan N. G., Analysis of islet inflammation in human type 1 diabetes Clinical and Experimental Immunology 2009 155 2 173 181
12. Conrad B., Weidmann E., Trucco G., Rudert W. A., Behboo R., Ricordi C., Rodriquez-Rilo H., Finegold D., Trucco M., Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology Nature 1994 371 6495 351 355 (Pubitemid 24300620)
13. Martin S., Wolf-Eichbaum D., Duinkerken G., Scherbaum W. A., Kolb H., Noordzij J. G., Roep B. O., Development of type 1 diabetes despite severe hereditary B-cell deficiency The New England Journal of Medicine 2001 345 14 1036 1040
14. Ziegler A. G., Nepom G. T., Prediction and pathogenesis in type 1 diabetes Immunity 2010 32 4 468 478
15. Sibley R. K., Sutherland D. E. R., Goetz F., Michael A. F., Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases Laboratory Investigation 1985 53 2 132 144 (Pubitemid 15049005)
16. Homo-Delarche F., Boitard C., Autoimmune diabetes: the role of the islets of Langerhans Immunology Today 1996 17 10 456 460
17. Daniel D., Gill R. G., Schloot N., Wegmann D., Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice European Journal of Immunology 1995 25 4 1056 1062
18. Thébault-Baumont K., Dubois-Laforgue D., Krief P., Briand J. P., Halbout P., Vallon-Geoffroy K., Morin J., Laloux V., Lehuen A., Carel J. C., Jami J., Muller S., Boitard C., Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice The Journal of Clinical Investigation 2003 111 6 851 857 (Pubitemid 37074960)
19. Moriyama H., Abiru N., Paronen J., Sikora K., Liu E., Miao D., Devendra D., Beilke J., Gianani R., Gill R. G., Elsenbarth G. S., Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse Proceedings of the National Academy of Sciences of the United States of America 2003 100 18 10376 10381 (Pubitemid 37071886)
20. Nakayama M., Beilke J. N., Jasinski J. M., Kobayashi M., Miao D., Li M., Coulombe M. G., Liu E., Elliott J. F., Gill R. G., Eisenbarth G. S., Priming and effector dependence on insulin B:9-23 peptide in NOD islet autoimmunity The Journal of Clinical Investigation 2007 117 7 1835 1843 (Pubitemid 47036317)
21. Yamamoto T., Yamato E., Tashiro F., Sato T., Noso S., Ikegami H., Tamura S., Yanagawa Y., Miyazaki J. I., Development of autoimmune diabetes in glutamic acid decarboxylase 65 (GAD65) knockout NOD mice Diabetologia 2004 47 2 221 224 (Pubitemid 38315358)
22. Kubosaki A., Miura J., Notkins A. L., IA-2 is not required for the development of diabetes in NOD mice Diabetologia 2004 47 1 149 150 (Pubitemid 38141956)
23. Zekzer D., Wong F. S., Ayalon O., Millet I., Altieri M., Shintani S., Solimena M., Sherwin R. S., GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice The Journal of Clinical Investigation 1998 101 1 68 73 (Pubitemid 28058904)
24. Lieberman S. M., Evans A. M., Han B., Takaki T., Vinnitskaya Y., Caldwell J. A., Serreze D. V., Shabanowitz J., Hunt D. F., Nathenson S. G., Santamaria P., DiLorenzo T. P., Identification of the cell antigen targeted by a prevalent population of pathogenic CD8 T cells in autoimmune diabetes Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8384 8388 (Pubitemid 36842554)
25. Haskins K., McDuffie M., Acceleration of diabetes in young NOD mice with a CD4 islet-specific T cell clone Science 1990 249 4975 1433 1436
26. Stadinski B. D., Delong T., Reisdorph N., Reisdorph R., Powell R. L., Armstrong M., Piganelli J. D., Barbour G., Bradley B., Crawford F., Marrack P., Mahata S. K., Kappler J. W., Haskins K., Chromogranin A is an autoantigen in type 1 diabetes Nature Immunology 2010 11 3 225 231
27. Yu L., Robles D. T., Abiru N., Kaur P., Rewers M., Kelemen K., Eisenbarth G. S., Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes Proceedings of the National Academy of Sciences of the United States of America 2000 97 4 1701 1706 (Pubitemid 30118506)
28. Ziegler A. G., Hummel M., Schenker M., Bonifacio E., Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study Diabetes 1999 48 3 460 468 (Pubitemid 29106857)
29. Keller R. J., Cellular immunity to human insulin in individuals at high risk for the development of type I diabetes mellitus Journal of Autoimmunity 1990 3 3 321 327 (Pubitemid 20337661)
30. Dubois-LaForgue D., Carel J. C., Bougnres P. F., Guillet J. G., Boitard C., T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes Journal of Clinical Immunology 1999 19 2 127 134 (Pubitemid 29187928)
31. Schloot N. C., Roep B. O., Wegmann D., Yu L., Chase H. P., Wang T., Eisenbarth G. S., Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects Diabetologia 1997 40 5 564 572 (Pubitemid 27186793)
32. Martinuzzi E., Novelli G., Scotto M., Blancou P., Bach J. M., Chaillous L., Bruno G., Chatenoud L., Van Endert P., Mallone R., The frequency and immunodominance of islet-specific CD8 T-cell responses change after type 1 diabetes diagnosis and treatment Diabetes 2008 57 5 1312 1320
33. Rudy G., Stone N., Harrison L. C., Colman P. G., McNair P., Brusic V., French M. B., Honeyman M. C., Tait B., Lew A. M., Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes Molecular Medicine 1995 1 6 625 633
34. Alleva D. G., Crowe P. D., Jin L., Kwok W. W., Ling N., Gottschalk M., Conlon P. J., Gottlieb P. A., Putnam A. L., Gaur A., A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin The Journal of Clinical Investigation 2001 107 2 173 180 (Pubitemid 32096833)
35. Petersen L. D., Duinkerken G., Bruining G. J., Van Lier R. A. W., De Vries R. R. P., Roep B. O., Increased numbers of in vivo activated T cells in patients with recent onset insulin-dependent diabetes mellitus Journal of Autoimmunity 1996 9 6 731 737 (Pubitemid 27047022)
36. Durinovic-Bell I., Schlosser M., Riedl M., Maisel N., Rosinger S., Kalbacher H., Deeg M., Ziegler M., Elliott J., Roep B. O., Karges W., Boehm B. O., Pro- and anti-inflammatory cytokine production by autoimmune T cells against preproinsulin in HLA-DRB1 04, DQ8 Type 1 diabetes Diabetologia 2004 47 3 439 450 (Pubitemid 38491240)
37. Naquet P., Ellis J., Tibensky D., Kenshole A., Singh B., Hodges R., Delovitch T. L., T cell autoreactivity to insulin in diabetic and related non-diabetic individuals The Journal of Immunology 1988 140 8 2569 2578
38. Panina-Bordignon P., Lang R., Van Endert P. M., Benazzi E., Felix A. M., Pastore R. M., Spinas G. A., Sinigaglia F., Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes Journal of Experimental Medicine 1995 181 5 1923 1927
39. Fineberg S. E., Kawabata T. T., Finco-Kent D., Fountaine R. J., Finch G. L., Krasner A. S., Immunological responses to exogenous insulin Endocrine Reviews 2007 28 6 625 652 (Pubitemid 47606649)
40. Durinovic-Bell I., Hummel M., Ziegler A. G., Cellular immune response to diverse islet cell antigens in IDDM Diabetes 1996 45 6 795 800 (Pubitemid 26166775)
41. Durinovic-Bell I., Hummel M., Ziegler A. G., Cellular immune response to diverse islet cell antigens in IDDM Diabetes 1996 45 6 795 800 (Pubitemid 26166775)
42. Tree T. I. M., Duinkerken G., Willemen S., De Vries R. R. P., Roep B. O., HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65 Diabetes 2004 53 7 1692 1699 (Pubitemid 38857026)
43. Di Lorenzo T. P., Peakman M., Roep B. O., Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes Clinical and Experimental Immunology 2007 148 1 1 16 (Pubitemid 46364983)
44. Raju R., Munn S. R., David C. S., T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice Human Immunology 1997 58 1 21 29 (Pubitemid 28027410)
45. Congia M., Patel S., Cope A. P., De Virgiliis S., Snderstrup G., T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin Proceedings of the National Academy of Sciences of the United States of America 1998 95 7 3833 3838 (Pubitemid 28173826)
46. Lee K. H., Wucherpfennig K. W., Wiley D. C., Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type I diabetes Nature Immunology 2001 2 6 501 507 (Pubitemid 33705851)
47. Havari E., Lennon-Dumenil A. M., Klein L., Neely D., Taylor J. A., McInerney M. F., Wucherpfennig K. W., Lipes M. A., Expression of the B7.1 costimulatory molecule on pancreatic cells abrogates the requirement for CD4 T cells in the development, of type 1 diabetes The Journal of Immunology 2004 173 2 787 796 (Pubitemid 38924253)
48. Arif S., Tree T. I., Astill T. P., Tremble J. M., Bishop A. J., Dayan C. M., Roep B. O., Peakman M., Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health The Journal of Clinical Investigation 2004 113 3 451 463 (Pubitemid 38544189)
49. Mannering S. I., Harrison L. C., Williamson N. A., Morris J. S., Thearle D. J., Jensen K. P., Kay T. W. H., Rossjohn J., Falk B. A., Nepom G. T., Purcell A. W., The insulin A-chain epitope recognized by human T cells is posttranslationally modified Journal of Experimental Medicine 2005 202 9 1191 1197 (Pubitemid 41586950)
50. Kent S. C., Chen Y., Bregoli L., Clemmings S. M., Kenyon N. S., Ricordi C., Hering B. J., Hafler D. A., Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope Nature 2005 435 7039 224 228 (Pubitemid 40685950)
51. Jensen P. E., Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant Journal of Experimental Medicine 1991 174 5 1121 1130
52. Miller G. G., Hoy J. F., Nell L. J., Thomas J. W., Antigen processing and the human T cell receptor repertoire for insulin The Journal of Immunology 1988 141 10 3293 3298
53. Chang L., Kjer-Nielsen L., Flynn S., Brooks A. G., Mannering S. I., Honeyman M. C., Harrison L. C., McCluskey J., Purcell A. W., Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin Tissue Antigens 2003 62 5 408 417 (Pubitemid 37338881)
54. Hassainya Y., Garcia-Pons F., Kratzer R., Lindo V., Greer F., Lemonnier F. A., Niedermann G., Van Endert P. M., Identification of naturally processed HLA-A2restricted proinsulin epitopes by reversed immunology Diabetes 2005 54 7 2053 2059 (Pubitemid 40911268)
55. Toma A., Haddouk S., Briand J. P., Camoin L., Gahery H., Connan F., Dubois-Laforgue D., Caillat-Zucman S., Guillet J. G., Carel J. C., Muller S., Choppin J., Boitard C., Recognition of a subregion of human proinsulin by class I-restricted T cells in type 1 diabetic patients Proceedings of the National Academy of Sciences of the United States of America 2005 102 30 10581 10586 (Pubitemid 41061597)
56. Toma A., Laka T., Haddouk S., Luce S., Briand J. P., Camoin L., Connan F., Lambert M., Caillat-Zucman S., Carel J. C., Muller S., Choppin J., Lemonnier F., Boitard C., Recognition of human proinsulin leader sequence by class I-restricted T-cells in HLA-A0201 transgenic mice and in human type 1 diabetes Diabetes 2009 58 2 394 402
57. Skowera A., Ellis R. J., Varela-Calvio R., Arif S., Huang G. C., Van-Krinks C., Zaremba A., Rackham C., Allen J. S., Tree T. I. M., Zhao M., Dayan C. M., Sewell A. K., Unger W., Drijfhout J. W., Ossendorp F., Roep B. O., Peakman M., CTLs are targeted to kill cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope The Journal of Clinical Investigation 2008 118 10 3390 3402
58. Pinkse G. G. M., Tysma O. H. M., Bergen C. A. M., Kester M. G. D., Ossendorp F., Van Veelen P. A., Keymeulen B., Pipeleers D., Drijfhout J. W., Roep B. O., Autoreactive CD8 T cells associated with cell destruction in type 1 diabetes Proceedings of the National Academy of Sciences of the United States of America 2005 102 51 18425 18430 (Pubitemid 43011242)
59. Larger E., Becourt C., Bach J. F., Boitard C., Pancreatic islet cells drive T cell-immune responses in the nonobese diabetic mouse model Journal of Experimental Medicine 1995 181 5 1635 1642
60. Velthuis J. H., Unger W. W., Abreu J. R. F., Duinkerken G., Franken K., Peakman M., Bakker A. H., Reker-Hadrup S., Keymeulen B., Drijfhout J. W., Schumacher T. N., Roep B. O., Simultaneous detection of circulating autoreactive CD8 + T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers Diabetes 2010 59 7 1721 1730
61. Peakman M., Tree T. I., Endl J., Van Endert P., Atkinson M. A., Roep B. O., Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the second international immunology of diabetes society workshop for standardization of T-cell assays in type 1 diabetes Diabetes 2001 50 8 1749 1754 (Pubitemid 33641592)
62. Lan M. S., Lu J., Goto Y., Notkins A. L., Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma DNA and Cell Biology 1994 13 5 505 514 (Pubitemid 24291404)
63. Rabin D. U., Pleasic S. M., Shapiro J. A., Yoo-Warren H., Oles J., Hicks J. M., Goldstein D. E., Rae P. M. M., Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases The Journal of Immunology 1994 152 6 3183 3188 (Pubitemid 24098017)
64. DeAizpurua H. J., Honeyman M. C., Harrison L. C., Glutamic acid decarboxylase (GAD) in fetal pig proislets is recognised by antibodies and stimulates T cells from humans with pre-clinical insulindependent diabetes mellitus Journal of Autoimmunity 1992 5 759 770
65. Harrison L. C., Honeyman M. C., DeAizpurua H. J., Schmidli R. S., Colman P. G., Tait B. D., Cram D. S., Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes The Lancet 1993 341 8857 1365 1369 (Pubitemid 23159984)
66. Lohmann T., Leslie R. D. G., Hawa M., Geysen M., Rodda S., Londei M., Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus The Lancet 1994 343 8913 1607 1608 (Pubitemid 24194810)
67. Honeyman M. C., Cram D. S., Harrison L. C., Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin- dependent diabetes Journal of Experimental Medicine 1993 177 2 535 540 (Pubitemid 23117105)
68. Atkinson M. A., Kaufman D. L., Campbell L., Gibbs K. A., Shah S. C., Bu D. F., Erlander M. G., Tobin A. J., Maclaren N. K., Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes The Lancet 1992 339 8791 458 459
69. Harrison L. C., Honeyman M. C., DeAizpurua H. J., Schmidli R. S., Colman P. G., Tait B. D., Cram D. S., Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes The Lancet 1993 341 8857 1365 1369 (Pubitemid 23159984)
70. Atkinson M. A., Bowman M. A., Campbell L., Darrow B. L., Kaufman D. L., Maclaren N. K., Cellular immunity to a determinant common to glutamate decarboxylase and Coxsackie virus in insulin-dependent diabetes The Journal of Clinical Investigation 1994 94 5 2125 2129 (Pubitemid 24348254)
71. Harrison L. C., Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes Molecular Medecine 1995 1 7 722 727 (Pubitemid 3013082)
72. Honeyman M. C., Stone N. L., Harrison L. C., T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA- 2: potential for mimicry with rotavirus and other environmental agents Molecular Medicine 1998 4 4 231 239 (Pubitemid 28331640)
73. Ott P. A., Herzog B. A., Quast S., Hofstetter H. H., Boehm B. O., Tary-Lehmann M., Durinovic-Bello I., Berner B. R., Lehmann P. V., Islet-cell antigen-reactive T cells show different expansion rates and Th1/Th2 differentiation in type 1 diabetic patients and healthy controls Clinical Immunology 2005 115 1 102 114 (Pubitemid 40616176)
74. Wicker L. S., Chen S. L., Nepom G. T., Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes- associated human MHC class II allele, DRB1 0401 The Journal of Clinical Investigation 1996 98 11 2597 2603 (Pubitemid 26415081)
75. Patel S. D., Cope A. P., Congia M., Chen T. T., Kim E., Fugger L., Wherrett D., Sonderstrup-Mcdevitt G., Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 by using HLA-DR( 1 0101, 1 0401) transgenic mice Proceedings of the National Academy of Sciences of the United States of America 1997 94 15 8082 8087 (Pubitemid 27343780)
76. Nepom G. T., Lippolis J. D., White F. M., Masewicz S., Marto J. A., Herman A., Luckey C. J., Falk B., Shabanowitz J., Hunt D. F., Engelhard V. H., Nepom B. S., Identification and modulation of a naturally processed T cell epitope from the diabetes-associated autoantigen human glutamic acid decarboxylase 65 (hGAD65) Proceedings of the National Academy of Sciences of the United States of America 2001 98 4 1763 1768 (Pubitemid 32165572)
77. Wen L. I., Wong F. S., Burkly L., Altieri M., Mamalaki C., Kioussis D., Flavell R. A., Sherwin R. S., Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4 T cells from human DQ transgenic mice The Journal of Clinical Investigation 1998 102 5 947 957 (Pubitemid 28419240)
78. Abraham R. S., Wilson S. B., De Souza N. F., Strominger J. L., Munn S. R., David C. S., NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice Human Immunology 1999 60 7 583 590 (Pubitemid 29328613)
79. Reijonen H., Novak E. J., Kochik S., Heninger A., Liu A. W., Kwok W. W., Nepom G. T., Detection of GAD65-specific T-cells by major histocompatibility complex class II tetramers in type 1 diabetic patients and at-risk subjects Diabetes 2002 51 5 1375 1382 (Pubitemid 34826602)
80. ling V., Marttila J., Ilonen J., Kwok W. W., Nepom G., Knip M., Simell O., Reijonen H., GAD65- and proinsulin-specific CD4 T-cells detected by MHC class II tetramers in peripheral blood of type 1 diabetes patients and at-risk subjects Journal of Autoimmunity 2005 25 3 235 243 (Pubitemid 41654469)
81. Endl J., Otto H., Jung G., Dreisbusch B., Donie F., Stahl P., Elbracht R., Schmilz G., Meinl E., Hummel M., Ziegler A. G., Wank R., Schendel D. J., Identification of naturally processed T cell epitopes from glutamic acid decarboxylase presented in the context of HLA-DR alleles by T lymphocytes of recent onset IDDM patients The Journal of Clinical Investigation 1997 99 10 2405 2415 (Pubitemid 27227718)
82. Gebe J. A., Unrath K. A., Yue B. B., Miyake T., Falk B. A., Nepom G. T., Autoreactive human T-cell receptor initiates insulitis and impaired glucose tolerance in HLA DR4 transgenic mice Journal of Autoimmunity 2008 30 4 197 206 (Pubitemid 351551499)
83. Gebe J. A., Yue B. B., Unrath K. A., Falk B. A., Nepom G. T., Restricted autoantigen recognition associated with deletional and adaptive regulatory mechanisms The Journal of Immunology 2009 183 1 59 65
84. Standifer N. E., Burwell E. A., Gersuk V. H., Greenbaum C. J., Nepom G. T., Changes in autoreactive T cell avidity during type 1 diabetes development Clinical Immunology 2009 132 3 312 320
85. Geluk A., Van Meijgaarden K. E., Schloot N. C., Drijfhout J. W., Ottenhoff T. H. M., Roep B. O., HLA-DR binding analysis of peptides from islet antigens in IDDM Diabetes 1998 47 10 1594 1601 (Pubitemid 28445347)
86. Harfouch-Hammoud E., Walk T., Otto H., Jung G., Bach J. F., Van Endert P. M., Caillat-Zucman S., Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes Diabetes 1999 48 10 1937 1947 (Pubitemid 29458355)
87. Fenalti G., Hampe C. S., Arafat Y., Law R. H. P., Banga J. P., Mackay I. R., Whisstock J. C., Buckle A. M., Rowley M. J., COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity Diabetes 2008 57 5 1293 1301
88. Ge X., Piganelli J. D., Tse H. M., Bertera S., Mathews C. E., Trucco M., Wen L. I., Rudert W. A., Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility Diabetes 2006 55 12 3455 3462 (Pubitemid 44923605)
89. Chang K. Y., Unanue E. R., Prediction of HLA-DQ8 cell peptidome using a computational program and its relationship to autoreactive T cells International Immunology 2009 21 6 705 713
90. Honeyman M. C., Stone N. L., Harrison L. C., T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA- 2: potential for mimicry with rotavirus and other environmental agents Molecular Medicine 1998 4 4 231 239 (Pubitemid 28331640)
91. Kelemen K., Gottlieb P. A., Putnam A. L., Davidson H. W., Wegmann D. R., Hutton J. C., HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 ) in human prediabetes The Journal of Immunology 2004 172 6 3955 3962 (Pubitemid 38337984)
92. Honeyman M. C., Stone N. L., Falk B. A., Nepom G., Harrison L. C., Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens The Journal of Immunology 2010 184 4 2204 2210
93. Weenink S. M., Lo J., Stephenson C. R., McKinney P. A., Ananieva-Jordanova R., Rees Smith B., Furmaniak J., Tremble J. M., Bodansky H. J., Christie M. R., Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes Journal of Autoimmunity 2009 33 2 147 154
94. Yang J., Danke N. A., Berger D., Reichstetter S., Reijonen H., Greenbaum C., Pihoker C., James E. A., Kwok W. W., Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4 + T cells in human subjects The Journal of Immunology 2006 176 5 2781 2789
95. Vendrame F., Pileggi A., Laughlin E., Allende G., Martin-Pagola A., Molano R. D., Diamantopoulos S., Standifer N., Geubtner K., Falk B. A., Ichii H., Takahashi H., Snowhite I., Chen Z., Mendez A., Chen L., Sageshima J., Ruiz P., Ciancio G., Ricordi C., Reijonen H., Nepom G. T., Burke G. W., Pugliese A., Recurrence of type 1 diabetes after simultaneous pancreas-kidney transplantation, despite immunosuppression, is associated with autoantibodies and pathogenic autoreactive CD4 T-cells Diabetes 2010 59 4 947 957
96. Mallone R., Martinuzzi E., Blancou P., Novelli G., Afonso G., Dolz M., Bruno G., Chaillous L., Chatenoud L., Bach J. M., Van Endert P., CD8+ T-cell responses identify -cell autoimmunity in human type 1 diabetes Diabetes 2007 56 3 613 621 (Pubitemid 46348452)
97. Takahashi K., Honeyman M. C., Harrison L. C., Cytotoxic T cells to an epitope in the islet autoantigen IA-2 are not disease-specific Clinical Immunology 2001 99 3 360 364
98. Panagiotopoulos C., Qin H., Tan R., Verchere C. B., Identification of a -cell-specific HLA class I restricted epitope in type 1 diabetes Diabetes 2003 52 11 2647 2651 (Pubitemid 37339692)
99. Standifer N. E., Ouyang Q., Panagiotopoulos C., Verchere C. B., Tan R., Greenbaum C. J., Pihoker C., Nepom G. T., Identification of novel HLA-A 0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives Diabetes 2006 55 11 3061 3067 (Pubitemid 44923643)
100. Ouyang Q., Standifer N. E., Qin H., Gottlieb P., Verchere C. B., Nepom G. T., Tan R., Panagiotopoulos C., Recognition of HLA class I-restricted -cell epitopes in type 1 diabetes Diabetes 2006 55 11 3068 3074 (Pubitemid 44923644)
101. Monti P., Scirpoli M., Rigamonti A., Mayr A., Jaeger A., Bonfanti R., Chiumello G., Ziegler A. G., Bonifacio E., Evidence for in vivo primed and expanded autoreactive T cells as a specific feature of patients with type 1 diabetes The Journal of Immunology 2007 179 9 5785 5792
102. Takaki T., Marron M. P., Mathews C. E., Guttmann S. T., Bottino R., Trucco M., DiLorenzo T. P., Serreze D. V., HLA-A 0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes The Journal of Immunology 2006 176 5 3257 3265
103. Blancou P., Mallone R., Martinuzzi E., Sévre S., Pogu S., Novelli G., Bruno G., Charbonnel B., Dolz M., Chaillous L., Van Endert P., Bach J. M., Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients The Journal of Immunology 2007 178 11 7458 7466 (Pubitemid 46847474)
104. Boitard C., Yasunami R., Dardenne M., T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice The Journal of Experimental Medecine 1989 169 5 1669 1680 (Pubitemid 19126824)
105. Kukreja A., Cost G., Marker J., Zhang C., Sun Z., Lin-Su K., Ten S., Sanz M., Exley M., Wilson B., Porcelli S., Maclaren N., Multiple immuno-regulatory defects in type-1 diabetes The Journal of Clinical Investigation 2002 109 1 131 140 (Pubitemid 34052549)
106. Liu W., Putnam A. L., Xu-yu Z., Szot G. L., Lee M. R., Zhu S., Gottlieb P. A., Kapranov P., Gingeras T. R., De St. Groth B. F., Clayberger C., Soper D. M., Ziegler S. F., Bluestone J. A., CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells Journal of Experimental Medicine 2006 203 7 1701 1711 (Pubitemid 44036276)
107. Tree T. I. M., Lawson J., Edwards H., Skowera A., Arif S., Roep B. O., Peakman M., Naturally arising human CD4+ T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression Diabetes 2010 59 6 1451 1460
108. Mallone R., Kochik S. A., Reijonen H., Carson B., Ziegler S. F., Kwok W. W., Nepom G. T., Functional avidity directs T-cell fate in autoreactive CD4+ T cells Blood 2005 106 8 2798 2805 (Pubitemid 41510756)
109. Durinovic-Bell I., Jelinek E., Schlosser M., Eiermann T., Boehm B. O., Karges W., Marchand L., Polychronakos C., Class III alleles at the insulin VNTR polymorphism are associated with regulatory T-cell responses to proinsulin epitopes in HLA-DR4, DQ8 individuals Diabetes 2005 54 supplement 2 S18 S24
110. Durinovic-Bell I., Rosinger S., Olson J. A., Congia M., Ahmad R. C., Rickert M., Hampl J., Kalbacher H., Drijfhout J. W., Mellins E. D., Al Dahouk S., Kamradt T., Maeurer M. J., Nhan C., Roep B. O., Boehm B. O., Polychronakos C., Nepom G. T., Karges W., McDevitt H. O., Snderstrup G., DRB1 0401-restricted human T cell clone specific for the major proinsulin 73-90 epitope expresses a down-regulatory T helper 2 phenotype Proceedings of the National Academy of Sciences of the United States of America 2006 103 31 11683 11688 (Pubitemid 44182511)
111. Danke N. A., Yang J., Greenbaum C., Kwok W. W., Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects Journal of Autoimmunity 2005 25 4 303 311 (Pubitemid 41642977)
112. Danke N. A., Koelle D. M., Yee C., Beheray S., Kwok W. W., Autoreactive T cells in healthy individuals The Journal of Immunology 2004 172 10 5967 5972 (Pubitemid 38621196)
113. Dromey J. A., Lee B. H., Yu H., Young H. E., Thearle D. J., Jensen K. P., Mannering S. I., Harrison L. C., Generation and expansion of regulatory human CD4(+) T-cell clones specific for pancreatic islet autoantigens Journal of Autoimmunity 2011 36 1 47 55
114. Long S. A., Cerosaletti K., Bollyky P. L., Tatum M., Shilling H., Zhang S., Zhang Z. Y., Pihoker C., Sanda S., Greenbaum C., Buckner J. H., Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects Diabetes 2010 59 2 407 415
115. Viglietta V., Kent S. C., Orban T., Hafler D. A., GAD65-reactive T cells are activated in patients with autoimmune type 1a diabetes The Journal of Clinical Investigation 2002 109 7 895 903 (Pubitemid 34275110)
116. Endl J., Rosinger S., Schwarz B., Friedrich S. O., Rothe G., Karges W., Schlosser M., Eiermann T., Schendel D. J., Boehm B. O., Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes Diabetes 2006 55 1 50 60 (Pubitemid 43343298)
117. James E. A., Kwok W. W., CD8 suppressor-mediated regulation of human CD4+ T cell responses to glutamic acid decarboxylase 65 European Journal of Immunology 2007 37 1 78 86 (Pubitemid 46128788)
118. Boitard C., Feutren G., Castano L., Debray-Sachs M., Assan R., Hors J., Bach J. F., Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients The Journal of Clinical Investigation 1987 80 6 1607 1612 (Pubitemid 18007131)
119. Roep B. O., Peakman M., Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes Nature Reviews Immunology 2010 10 2 145 152
120. Secrest A. M., Becker D. J., Kelsey S. F., LaPorte R. E., Orchard T. J., Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes Diabetes 2010 59 12 3216 3222
121. Tian J., Kaufman D. L., Antigen-based therapy for the treatment of type 1 diabetes Diabetes 2009 58 9 1939 1946
122. Miller S. D., Turley D. M., Podojil J. R., Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease Nature Reviews Immunology 2007 7 9 665 677 (Pubitemid 47327394)
123. Salomon B., Rhee L., Bour-Jordan H., Hsin H., Montag A., Soliven B., Arcella J., Girvin A. M., Miller S. D., Bluestone J. A., Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice Journal of Experimental Medicine 2001 194 5 677 684 (Pubitemid 32844777)
124. Prevot N., Briet C., Lassmann H., Abrogation of ICOS/ICOSL costimulation in NOD mice results in autoimmune deviation towards the neuromuscular system European Journal of Immunology 2010 40 2267 2276
125. Shah S. C., Malone J. I., Simpson N. E., A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus The New England Journal of Medicine 1989 320 9 550 554 (Pubitemid 19070538)
126. Schnell O., Eisfelder B., Standl E., High-dose intravenous insulin infusion versus intensive insulin treatment in newly diagnosed IDDM Diabetes 1997 46 10 1607 1611
127. The Diabetes Control and Complications Trial, Effect of intensive therapy on residual -cell function in patients with type 1 diabetes in the Diabetes Control and Complications Trial Annals of Internal Medecine 1998 128 517 523
128. Harrison L. C., Honeyman M. C., Steele C. E., Stone N. L., Sarugeri E., Bonifacio E., Couper J. J., Colman P. G., Pancreatic -cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes Diabetes Care 2004 27 10 2348 2355 (Pubitemid 39281384)
129. diabetes Prevention TrialType 1 Diabetes Study Group, Effects of insulin in relatives of patients with Type 1 Diabetes Mellitus The New England Journal of Medecine 2002 346 1685 1691
130. Skyler J. S., Krischer J. P., Wolfsdorf J., Effects of oral insulin in relatives of patients with type 1 diabetes: the diabetes prevention trial-type 1 Diabetes Care 2005 28 5 1068 1076 (Pubitemid 40616615)
131. Nnt-Salonen K., Kupila A., Simell S., Siljander H., Salonsaari T., Hekkala A., Korhonen S., Erkkola R., Sipil J. I., Haavisto L., Siltala M., Tuominen J., Hakalax J., Hyty H., Ilonen J., Veijola R., Simell T., Knip M., Simell O., Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial The Lancet 2008 372 9651 1746 1755
132. Chaillous L., Lefvre H., Thivolet C., Boitard C., Lahlou N., Atlan-Gepner C., Bouhanick B., Mogenet A., Nicolino M., Carel J.-C., Lecomte P., Maréchaud R., Bougnres P., Charbonnel B., Sa P., Oral insulin administration and residual -cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial The Lancet 2000 356 9229 545 549 (Pubitemid 30611859)
133. Pozzilli P., Pitocco D., Visalli N., Cavallo M. G., Buzzetti R., Crin A., Spera S., Suraci C., Multari G., Cervoni M., Manca Bitti M. L., Matteoli M. C., Marietti G., Ferrazzoli F., Cassone Faldetta M. R., Giordano C., Sbriglia M., Sarugeri E., Ghirlanda G., No effect of oral insulin on residual beta-cell function in recent-onset Type I diabetes (the IMDIAB VII) Diabetologia 2000 43 8 1000 1004 (Pubitemid 30655719)
134. Orban T., Farkas K., Jalahej H., Kis J., Treszl A., Falk B., Reijonen H., Wolfsdorf J., Ricker A., Matthews J. B., Tchao N., Sayre P., Bianchine P., Autoantigen-specific regulatory T cells induced in patients with type 1 diabetes mellitus by insulin B-chain immunotherapy Journal of Autoimmunity 2010 34 4 408 415
135. Maruyama T., Tanaka S., Shimada A., Funae O., Kasuga A., Kanatsuka A., Takei I., Yamada S., Harii N., Shimura H., Kobayashi T., Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus Journal of Clinical Endocrinology and Metabolism 2008 93 6 2115 2121 (Pubitemid 351831524)
136. Alvarsson M., Sundkvist G., Lager I., Berntorp K., Fernqvist-Forbes E., Steen L., rn T., Holberg M. A., Kirksther N., Grill V., Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4-year follow-up Diabetes, Obesity and Metabolism 2008 10 5 421 429 (Pubitemid 351524289)
137. Agardh C. D., Cilio C. M., Lethagen A., Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes Journal of Diabetes and its Complications 2005 19 4 238 246 (Pubitemid 40910206)
138. Ludvigsson J., Faresj M., Hjorth M., GAD treatment and insulin secretion in recent-onset type 1 diabetes The New England Journal of Medicine 2008 359 18 1909 1920
139. Raz I., Elias D., Avron A., Tamir M., Metzger M., Cohen I. R., -cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial The Lancet 2001 358 9295 1749 1753 (Pubitemid 33152998)
140. Semana G., Gausling R., Jackson R. A., Hafler D. A., T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects Journal of Autoimmunity 1999 12 4 259 267 (Pubitemid 29261962)
141. Durinovic-Bell I., Boehm B. O., Ziegler A. G., Predominantly recognized ProInsulin T helper cell epitopes in individuals with and without islet cell autoimmunity Journal of Autoimmunity 2002 18 1 55 66 (Pubitemid 34252594)
142. Kimura K., Kawamura T., Kadotani S., Inada H., Niihira S., Yamano T., Peptide-specific cytotoxicity of T lymphocytes against glutamic acid decarboxylase and insulin in type 1 diabetes mellitus Diabetes Research and Clinical Practice 2001 51 3 173 179 (Pubitemid 32223911)